Swarajya Logo
  • Morning Brief
  • States
  • Politics
  • Economy
  • Business
  • Culture
  • Infra
  • Defence
  • World
  • Books
  • Ideas
  • Science
  • Technology
  • Heritage
  • Archives
  • Our Views
  • Magazine
  • Headlines
  • Store

Sinopharm

Singaporeans Turn To Pfizer Covid Jab After Receiving Two Doses Of Chinese Vaccines

Bhaswati Guha Majumder
3y News Brief
image

Chinese Covid-19 Vaccines Not As Effective Against Delta Variant: China Disease Control Researcher

Swarajya Staff
4y Insta
image

Battling Covid-19 Surge, Bahrain Approves Pfizer-BioNTech Booster Shot For People Already Given Chinese Vaccines

Tarkesh Jha
4y Insta
image

Countries Like Seychelles, Mongolia, Bahrain That Relied On Chinese Covid-19 Vaccines Report Fresh Wave Of Infections

Swarajya Staff
4y Insta
image

Explained: China’s ‘PR’ Strategy To Vaccinate The World With Less Effective Covid-19 Jabs 

Bhaswati Guha Majumder
4y News Headlines
image

China’s Vaccine Diplomacy Hits A Hurdle In Nepal As It Insists On Signing Non-Disclosure Agreement: Report

Swarajya Staff
4y Insta
image

Two Weeks After Receiving First Dose Of Chinese Covid-19 Vaccine, Pak President Arif Alvi Tests Positive For Coronavirus

IANS
4y News Brief
image

Peru Suspends Trial For Chinese COVID-19 Vaccine After A Volunteer Develops Neurological Problems 

Swarajya Staff
4y Insta
image

Safety Concerns Raised Over China Administering Experimental Covid-19 Vaccines To Thousands Of Its Citizens

Swarajya Staff
4y Insta
image

China Has Already Begun To Vaccinate People With Under-Trial Covid-19 Vaccine By Sinopharm: Report

Swarajya Staff
4y Insta
image

Get Swarajya in your inbox.


About Swarajya

Shaping the modern Indian's worldview, speaking on behalf of those invested in the cultural and economic prosperity of India. Published since 1956.


Swarajya is a publication by Kovai Media Private Limited.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.
    Artboard 2 Copy 10Created with Sketch.
    Artboard 2 Copy 7Created with Sketch.
    Artboard 2 Copy 9Created with Sketch.
  • Andriod Logo
  • IOS Logo